Replies to post #4771 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Is the control arm in the phase III ART-123 study heparin or nothing?<

The ART-123 program has not yet reached phase-3; in phase-2b (the trial that was just announced), the control arm is placebo, according to the description at http://www.clinicaltrials.gov/ct/show/NCT00487656 . Regards, Dew